SILVERBACK ASSET MANAGEMENT LLC
Registered adviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Apr 2026 to Nov 2026 | $1,192,470,794 | Corporations (65%) |
| Dec 2025 to Mar 2026 | $1,043,312,563 | Corporations (69%) |
| Apr 2025 to Sep 2025 | $1,043,032,522 | Corporations (75%) |
| Apr 2024 to Mar 2025 | $957,254,833 | Corporations (77%) |
| May 2023 to Mar 2024 | $846,247,220 | Corporations (69%) |
| Apr 2023 | $846,247,220 | Corporations (69%) |
In the firm's words
- Quantitative / systematic:
the use of quantitative tools, models and investment approaches
- Fundamental active:
These strategies generally seek to take advantage of fundamentally driven investment analysis paired with appropriate security selection to monetize views held primarily (but not only) in credit, equity and volatility related investments.
- Fixed income / rates:
an opportunistic credit, convertible arbitrage and/or a special situations strategy
- Multi-asset:
The Adviser actively manages exposures to equity, credit, volatility and interest rates
- Long/short hedge:
To implement hedges and hedging strategies the Adviser engages in short selling and options trading
Schedule 13D/13G stakes
Stakes of 5% or more disclosed on Schedule 13D or 13G, each on the filer's latest filing for the security. These are event-dated stakes, not the quarter-end 13F portfolio below.
| Company | Schedule | Event date | Filed | Shares | % of class | Status |
|---|---|---|---|---|---|---|
| VRM Vroom, Inc. | 13G | Mar 31, 2025 | 1y | 424,873 | 8.23% | Current |
A 13D or 13G stays in force until its filer amends it and no amendment is due without a material change, so a stake with no filing in 24 months reads unconfirmed, never sold. An amendment reporting under 5% ends the filer's duty to amend, not necessarily the holding. Shares are restated onto today's split basis.
Portfolio style
Measured from the filed 13F common-share book for Sep 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2026-09-30, active share 99.5%; sector active share 51.9% against the combined 13F book's sector weights.
Over time 27 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+. Stocks and the top 10 weight count issuers: share classes of one company are one stock, and options are left out, so they can differ from the position count and top 10 concentration of GetInstitutionSummary and GetInstitutionPortfolio, which count each listed share class.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
14 common stock positions · as of Sep 30, 2026 · Δ vs Jun 30, 2026Portfolio Trend
Sector Breakdown
Common stock positions · as of Sep 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 71.5% | $19,363,495 |
| Financial Services | 21.7% | $5,882,066 |
| Healthcare | 6.5% | $1,756,500 |
| Consumer Cyclical | 0.3% | $83,435 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reducedNew Positions
Positions the filer opened this quarter| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| HYG |
iShares iBoxx $ High Yield Corporate Bond ETF
PUT
|
NEW | 2,500,000 | $193,025,000 | 48.64% | |
| IWM |
iShares Russell 2000 ETF
CALL
|
Added | 375,000 | $104,208,750 | 26.26% | |
| DFTX |
Definium Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
Added | 439,400 | $16,723,564 | 4.21% | |
| SPY |
Spdr S&P 500 ETF Trust
CALL
|
NEW | 15,000 | $11,439,450 | 2.88% | |
| QQQ |
Invesco Qqq Trust, Series 1
CALL
|
NEW | 15,000 | $11,096,550 | 2.80% | |
| SOUN |
Soundhound Ai, Inc.
Technology
|
NEW | 1,495,720 | $9,004,234 | 2.27% | |
| XLV |
State Street(R) Health Care Select Sector SPDR(R) ETF
CALL
|
Held | 50,000 | $8,421,000 | 2.12% | |
| XBI |
State Street(R) SPDR(R) S&P(R) Biotech ETF
CALL
|
Held | 50,000 | $7,884,000 | 1.99% | |
| NTNX |
Nutanix, Inc.
CALL
Technology
|
Held | 100,000 | $7,041,000 | 1.77% | |
| CYTK |
Cytokinetics Inc
CALL
Healthcare
|
Held | 100,000 | $6,591,000 | 1.66% | |
| HLIT |
Harmonic Inc.
Technology
|
Added | 549,890 | $5,806,838 | 1.46% | |
| VRM |
Vroom, Inc.
Financial Services
|
Added | 449,736 | $4,452,386 | 1.12% | |
| CORZ |
Core Scientific, Inc.
Technology
|
Held | 131,600 | $2,102,968 | 0.53% | |
| SITM |
SITIME Corp
Technology
|
NEW | 3,180 | $2,073,455 | 0.52% | |
| LCID |
Lucid Group, Inc.
PUT
+ SHARES
Consumer Cyclical
|
Added | 490,500 | $1,996,335 | 0.50% | |
| WULF |
Terawulf Inc.
Financial Services
|
Held | 96,600 | $1,429,680 | 0.36% | |
| PAR |
Par Technology Corp
CALL
Technology
|
Reduced | 100,000 | $1,376,000 | 0.35% | |
| EYPT |
EyePoint, Inc.
CALL
+ SHARES
Healthcare
|
Held | 150,000 | $490,500 | 0.12% | |
| ARAY |
Accuray Inc
Healthcare
|
Held | 1,450,000 | $391,500 | 0.10% | |
| MX |
MAGNACHIP SEMICONDUCTOR Corp
Technology
|
Held | 100,000 | $376,000 | 0.09% | |
| EVMN |
Evommune, Inc.
Healthcare
|
NEW | 40,000 | $330,400 | 0.08% | |
| CTMX |
CytomX Therapeutics, Inc.
CALL
Healthcare
|
NEW | 100,000 | $272,000 | 0.07% | |
| OCGN |
Ocugen, Inc.
Healthcare
|
Held | 250,000 | $257,500 | 0.06% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
Reduced | 35,000 | $42,700 | 0.01% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.